The Journal of Urology
Volume 170, Issue 5 , Pages 1717-1721 , November 2003

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

,Accepted 9 May 2003.

REFERENCES 

  1. Pound CR . Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer . Rev Urol . 2001;3:72
  2. Stanford JL , Stephenson RA , Coyle LM , Cerhan J , Correa R , Eley JW , et al.   Prostate Cancer Trends 1973–1995, SEER Program, National Cancer Institute . Bethesda, MD: National Institute of Health; 1999; Publication No. 99-4543
  3. Kantoff PW , Halabi S , Conaway M , Picus J , Kirshner J , Hars V , et al.   Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study . J Clin Oncol . 1999;17:2506
  4. Oh WK , Kantoff PW . Management of hormone refractory prostate cancer: current standards and future prospects . J Urol . 1998;160:1220
  5. Horoszewicz JS , Kawinski E , Murphy GP . Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients . Anticancer Res . 1987;7:927
  6. Israeli RS , Powell CT , Fair WR , Heston WD . Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen . Cancer Res . 1993;53:227
  7. Israeli RS , Powell CT , Corr JG , Fair WR , Heston WD . Expression of the prostate-specific membrane antigen . Cancer Res . 1994;54:1807
  8. Wright GL , Haley C , Beckett ML , Schellhammer PF . Expression of prostate-specific membrane antigen (PSMA) in normal, benign and malignant prostate tissues . Urol Oncol . 1995;1:18
  9. Troyer JK , Beckett ML , Wright GL . Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids . Int J Cancer . 1995;62:552
  10. Sokoloff RL , Norton KC , Gasior CL , Marker KM , Grauer LS . A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine . Prostate . 2000;43:150
  11. Bostwick DG , Pacelli A , Blute M , Roche P , Murphy GP . Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases . Cancer . 1998;82:2256
  12. Wright GL , Grob B , Haley C , Grossman K , Newhall K , Petrylak D , et al.   Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy . Urology . 1996;48:326
  13. Sweat SD , Pacelli A , Murphy GP , Bostwick DG . Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases . Urology . 1998;52:637
  14. Wynant GE , Murphy GP , Horoszewicz JS , Neal CE , Collier BD , Mitchell E , et al.   Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11–C5.3 (CYT-356) . Prostate . 1991;18:229
  15. Deb N , Goris M , Trisler K , Fowler S , Saal J , Ning S , et al.   Treatment of hormone-refractory prostate cancer with 90Y-CYT-356 monoclonal antibody . Clin Cancer Res . 1996;2:1289
  16. Troyer JK , Feng Q , Beckett ML , Wright GL . Biochemical characterization and mapping of the 7E11–C5. 3 epitope of the prostate-specific membrane antigen . Urol Oncol . 1995;1:29
  17. Troyer JK , Beckett ML , Wright GL . Location of prostate-specific membrane antigen in the LNCaP prostate carcinoma cell line . Prostate . 1997;30:232
  18. Smith-Jones PM , Vallabhajosula S , Navarro V , Bastidas D , Goldsmith SJ , Bander NH . Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor . J Nucl Med . 2003;44:610
  19. Liu H , Moy P , Kim S , Xia Y , Rajasekaran A , Navarro V , et al.   Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium . Cancer Res . 1997;57:3629
  20. Hamilton A , King S , Liu H , Moy P , Bander N , Carr F . A novel humanized antibody against prostate specific membrane antigen (PSMA) for in vivo targeting and therapy . Proc Am Assoc Cancer Res . 1998;39:440

 Editor’s Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1982 and 1983.Supported by National Institutes of Health General Clinical Research Centers Program (National Center for Research Resources Grant M01RR00047), U.S. Department of Army Grant DAMD17-98-1-8594, the Cancer Research Institute, CaPCURE, the David H. Koch Foundation, the Peter Sacerdote Foundation, the Yablans Research Fund and the Gerschel Research Fund.

PII: S0022-5347(05)62918-7

doi: 10.1097/01.ju.0000091655.77601.0c

The Journal of Urology
Volume 170, Issue 5 , Pages 1717-1721 , November 2003

Article Tools

* Image Usage & Resolution